查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942753

2026年全球DNA與基因晶片市場報告

DNA And Gene Chip Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，DNA和基因晶片市場發展迅速，預計從2025年的92億美元成長到2026年的104.5億美元，複合年成長率達13.6%。過去幾年的成長可歸因於基因組研究活動的擴展、分子診斷技術的日益普及、癌症研究計畫的增加、先進微陣列平台的普及以及學術基因組研究經費的增加。

預計未來幾年，DNA和基因晶片市場將快速成長，到2030年市場規模將達到169.9億美元，複合年成長率（CAGR）為12.9%。預測期內的成長可歸因於以下因素：對個人化醫療的日益關注、對基於基因組的藥物研發投入的增加、大規模人群基因篩檢的擴展、人工智慧驅動的基因組分析的日益普及以及基因晶片在農業基因組學中應用的不斷擴大。預測期內的關鍵趨勢包括：高密度基因表現晶片的日益普及、單細胞分析晶片的廣泛應用、對精準腫瘤診斷的需求不斷成長、SNP和全基因組分析晶片的廣泛應用以及對高通量基因組篩檢的日益重視。

對癌症早期檢測日益重視，是推動DNA和基因晶片市場擴張的主要動力。癌症是指幾乎任何器官或組織中，異常細胞不受控制地生長、突破正常細胞邊界、侵入周圍組織並轉移到身體其他部位所致的一系列疾病。人們對癌症早期檢測益處的認知不斷提高，推動了早期檢測的需求，鼓勵人們及時接受篩檢，從而顯著改善治療效果和提高生存率。 DNA和基因晶片被廣泛用於分析基因表現、評估遺傳和表觀遺傳變化，以及分析惡性細胞中與癌症相關轉錄因子相關的基因組調控元件。例如，根據美國國家癌症研究所2025年5月發布的報告，預計美國在2025年將新增約2,041,910例癌症病例，並有618,120例癌症相關死亡病例。同樣，美國癌症協會的數據預測，2022年美國將新增約190萬例癌症病例，並有609,360例癌症死亡病例。因此，人們對癌症早期檢測日益成長的興趣正在推動DNA和基因晶片市場的成長。

DNA和基因晶片市場的主要企業正在開發創新基因分型晶片，例如Axiom YNS_Mol1，以促進食品產業的發展和昆蟲作為食品來源的廣泛應用。 Axiom YNS_Mol1是專為飼養家蟋蟀（黃粉蟲，Tenebrio molitor）而設計的基因分型晶片。例如，2023年6月，專注於昆蟲生產的法國公司Ynsect發布了全球首款用於昆蟲飼養的基因分型晶片Axiom YNS_Mol1。這款開創性的晶片由Ynsect與賽默飛世爾科技公司（Thermo Fisher Scientific）合作開發，旨在革新昆蟲養殖方式，實現永續的食品和寵物食品生產。它能夠分析穀蟲（Tenebrio molitor）的遺傳特徵，從而改善其生長、繁殖和抗病性等特性，並提高基因組多樣性。這項創新措施是Ynsect的YnFABRE計劃的一部分，有助於為應對環境挑戰提供永續的解決方案，並推動昆蟲養殖技術的發展。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球DNA及基因晶片市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 永續性、氣候技術和循環經濟
  • 主要趨勢
    • 高密度基因表現晶片的廣泛應用
    • 單細胞分析晶片的應用日益廣泛
    • 精準腫瘤診斷的需求日益成長
    • SNP和全基因組分析晶片的擴展
    • 人們對高通量基因組篩檢的興趣日益濃厚

第5章 終端用戶產業市場分析

  • 學術和政府研究機構
  • 生技公司
  • 製藥公司
  • 醫院和診斷中心
  • 合約研究機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球DNA與基因晶片市場：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球DNA及基因晶片市場規模、比較及成長率分析
  • 全球DNA與基因晶片市場表現：規模與成長，2020-2025年
  • 全球DNA和基因晶片市場預測：規模和成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 寡核苷酸DNA（o-DNA）、互補DNA（c-DNA）
  • 透過使用
  • 癌症診斷、基因表現、基因組學、藥物發現、農業基因組學
  • 最終用戶
  • 學術和政府研究機構、生物技術和製藥公司、醫院和診斷中心以及其他最終用戶
  • 依類型進行亞片段化：寡核苷酸DNA（o-DNA）
  • 客製化寡核苷酸晶片，市售寡核苷酸陣列
  • 依類型進行亞片段化：互補DNA（c-DNA）
  • cDNA微陣列，cDNA表現陣列

第10章 區域與國家分析

  • 全球DNA與基因晶片市場：區域分析、預測與成長，2020-2025年、2025-2030年預測、2035年預測
  • 全球DNA與基因晶片市場：依國家分類，實際值及預測值，2020-2025年、2025-2030年預測值、2035年預測值

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • DNA與基因晶片市場：競爭格局與市場佔有率（2024年）
  • DNA與基因晶片市場：公司估值矩陣
  • DNA與基因晶片市場：公司概況
    • Illumina Inc.
    • Thermo Fisher Scientific Inc.
    • Agilent Technologies Inc.
    • PerkinElmer Inc.
    • CapitalBio Corporation

第37章：其他領先和創新企業

  • Microarrays Inc., Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, QIAGEN NV, Bio-Rad Laboratories Inc., BioChain Institute Inc., Fluidigm Corporation, LC Sciences, Macrogen Inc., Greiner Bio-One International GmbH, F. Hoffmann-La Roche Ltd, GE Healthcare, Hitachi High-Technologies Corporation

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • DNA與基因晶片市場展望（2030年）：蘊藏新機會的國家
  • DNA與基因晶片市場2030：充滿新機會的細分市場
  • DNA與基因晶片市場2030年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MDGCE01_G26Q1

A DNA and gene chip is a microchip featuring microscopic DNA probes attached to a solid surface, capable of identifying DNA from test samples and constituting one half of the DNA double helix. When the test sample of DNA carries a mutation, the DNA fails to bind properly to the sequence on the chip. This technology is employed to measure the expression levels of genes or determine whether a person's DNA exhibits mutations, variations in DNA that can lead to diseases.

The main types of DNA and gene chips include oligonucleotide DNA (O-DNA), complementary DNA (C-DNA), and other variations. Oligonucleotide DNA comprises short single- or double-stranded DNA or RNA fragments with three to twenty nucleotides. Products associated with this technology include consumables and instruments, with applications ranging from cancer diagnostics, gene expression, proteomics, genomics, drug discovery, to agrigenomics. End-user industries involved encompass academic and government research institutes, biotechnology and pharmaceutical companies, hospitals and diagnostics centers, among others.

Tariffs are impacting the dna and gene chip market by increasing costs of imported microarray substrates, reagents, scanners, and semiconductor-based fabrication equipment used in chip production. Research institutions and biotechnology companies in North America and Europe are most affected due to dependence on imported precision components, while Asia-Pacific faces higher costs for export-oriented chip manufacturing. These tariffs are increasing procurement expenses and slowing laboratory upgrades. However, they are also encouraging localized manufacturing, domestic reagent production, and regional expansion of genomics fabrication facilities.

The dna and gene chip market research report is one of a series of new reports from The Business Research Company that provides dna and gene chip market statistics, including dna and gene chip industry global market size, regional shares, competitors with a dna and gene chip market share, detailed dna and gene chip market segments, market trends and opportunities, and any further data you may need to thrive in the dna and gene chip industry. This dna and gene chip market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dna and gene chip market size has grown rapidly in recent years. It will grow from $9.2 billion in 2025 to $10.45 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to expansion of genomic research activities, increasing adoption of molecular diagnostics, growth of cancer research programs, rising availability of advanced microarray platforms, expansion of academic genomics funding.

The dna and gene chip market size is expected to see rapid growth in the next few years. It will grow to $16.99 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to increasing focus on personalized medicine, rising investments in genomics-based drug discovery, expansion of population-scale genetic screening, growing adoption of ai-driven genomic analytics, increasing use of gene chips in agrigenomics. Major trends in the forecast period include increasing adoption of high-density gene expression arrays, rising use of single-cell analysis chips, growing demand for precision oncology diagnostics, expansion of snp and whole genome analysis chips, enhanced focus on high-throughput genomic screening.

The growing emphasis on early cancer detection is playing a major role in driving the expansion of the DNA and gene chip market. Cancer refers to a wide range of diseases that can originate in almost any organ or tissue when abnormal cells grow uncontrollably, breach normal cellular boundaries, invade surrounding tissues, and spread to other parts of the body. The demand for early detection is increasing as awareness rises about the advantages of identifying cancer at an early stage, encouraging individuals to undergo timely screening that can significantly improve treatment effectiveness and survival rates. DNA and gene chips are widely used to analyze gene expression profiles, assess genetic and epigenetic alterations, and evaluate genomic regulatory elements associated with cancer-related transcription factors in malignant cells. For example, in May 2025, a report published by the National Cancer Institute indicated that the United States is expected to record around 2,041,910 new cancer cases and approximately 618,120 cancer-related deaths in 2025. Similarly, in 2022, data from the American Cancer Society projected nearly 1.9 million newly diagnosed cancer cases and 609,360 deaths in the United States. Consequently, the increasing focus on early cancer detection is supporting the growth of the DNA and gene chip market.

Key players in the DNA and gene chip market are developing innovative genotyping chips, such as the Axiom YNS_Mol1, to advance the food industry and promote insect consumption. The Axiom YNS_Mol1 is a genotyping chip specifically designed for insect breeding, particularly for the Tenebrio Molitor mealworm. For instance, in June 2023, Ynsect, a France-based company specializing in insect production, introduced the world's first genotyping chip for insect breeding, the Axiom YNS_Mol1. Developed in collaboration with Thermo Fisher Scientific, this pioneering chip aims to transform insect breeding for sustainable food and pet food production. It analyzes genetic traits to enhance genomic diversity and improve characteristics such as growth, reproduction, and disease resistance in Tenebrio Molitor mealworms. This innovative initiative is part of Ynsect's YnFABRE project, contributing to the advancement of entomoculture and sustainable solutions in addressing environmental challenges.

In December 2024, Hendrix Genetics, a Netherlands-based animal breeding technology company, entered into a partnership with LABOGENA DNA to obtain exclusive access to high-throughput genotyping services for its multi-species breeding programs. Through this collaboration, Hendrix Genetics seeks to strengthen and accelerate its genotyping capabilities, enabling improved genetic gains across multiple species by leveraging LABOGENA DNA's advanced genotyping infrastructure. LABOGENA DNA, a France-based industrial genotyping and sequencing company, specializes in high-throughput single nucleotide polymorphism (SNP) chip genotyping, targeted sequencing, DNA extraction, custom SNP matrix development, and research and development consulting services, all delivered from its International Organization for Standardization (ISO) 17025-accredited laboratory located near Paris.

Major companies operating in the dna and gene chip market are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., CapitalBio Corporation, Microarrays Inc., Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Fluidigm Corporation, LC Sciences, Macrogen Inc., Greiner Bio-One International GmbH, F. Hoffmann-La Roche Ltd, GE Healthcare, Hitachi High-Technologies Corporation

North America was the largest region in the DNA and gene chip market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna and gene chip market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dna and gene chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The DNA and gene chip market consists of sales of instrumentation and consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA And Gene Chip Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses dna and gene chip market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna and gene chip ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dna and gene chip market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Oligonucleotide DNA (o-DNA); Complementary DNA (c-DNA)
  • 2) By Application: Cancer Diagnostics; Gene Expression; Genomics; Drug Discovery; Agrigenomics
  • 3) By End User: Academic And Government Research Institutes; Biotechnology And Pharmaceutical Companies; Hospitals And Diagnostics Centers; Other End Users
  • Subsegments:
  • 1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips; Commercial Oligonucleotide Arrays
  • 2) By Complementary DNA (c-DNA): cDNA Microarrays; cDNA Expression Arrays
  • Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; CapitalBio Corporation; Microarrays Inc.; Applied Microarrays Inc.; Biometrix Technology Inc.; Oxford Gene Technology IP Limited; Bioneer Corporation; QIAGEN N.V.; Bio-Rad Laboratories Inc.; BioChain Institute Inc.; Fluidigm Corporation; LC Sciences; Macrogen Inc.; Greiner Bio-One International GmbH; F. Hoffmann-La Roche Ltd; GE Healthcare; Hitachi High-Technologies Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. DNA And Gene Chip Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global DNA And Gene Chip Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. DNA And Gene Chip Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global DNA And Gene Chip Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of High-Density Gene Expression Arrays
    • 4.2.2 Rising Use Of Single-Cell Analysis Chips
    • 4.2.3 Growing Demand For Precision Oncology Diagnostics
    • 4.2.4 Expansion Of Snp And Whole Genome Analysis Chips
    • 4.2.5 Enhanced Focus On High-Throughput Genomic Screening

5. DNA And Gene Chip Market Analysis Of End Use Industries

  • 5.1 Academic And Government Research Institutes
  • 5.2 Biotechnology Companies
  • 5.3 Pharmaceutical Companies
  • 5.4 Hospitals And Diagnostics Centers
  • 5.5 Contract Research Organizations

6. DNA And Gene Chip Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global DNA And Gene Chip Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global DNA And Gene Chip PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global DNA And Gene Chip Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global DNA And Gene Chip Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global DNA And Gene Chip Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global DNA And Gene Chip Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. DNA And Gene Chip Market Segmentation

  • 9.1. Global DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA)
  • 9.2. Global DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer Diagnostics, Gene Expression, Genomics, Drug Discovery, Agrigenomics
  • 9.3. Global DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users
  • 9.4. Global DNA And Gene Chip Market, Sub-Segmentation Of Oligonucleotide DNA (o-DNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays
  • 9.5. Global DNA And Gene Chip Market, Sub-Segmentation Of Complementary DNA (c-DNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • cDNA Microarrays, cDNA Expression Arrays

10. DNA And Gene Chip Market Regional And Country Analysis

  • 10.1. Global DNA And Gene Chip Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global DNA And Gene Chip Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific DNA And Gene Chip Market

  • 11.1. Asia-Pacific DNA And Gene Chip Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China DNA And Gene Chip Market

  • 12.1. China DNA And Gene Chip Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India DNA And Gene Chip Market

  • 13.1. India DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan DNA And Gene Chip Market

  • 14.1. Japan DNA And Gene Chip Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia DNA And Gene Chip Market

  • 15.1. Australia DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia DNA And Gene Chip Market

  • 16.1. Indonesia DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea DNA And Gene Chip Market

  • 17.1. South Korea DNA And Gene Chip Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan DNA And Gene Chip Market

  • 18.1. Taiwan DNA And Gene Chip Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia DNA And Gene Chip Market

  • 19.1. South East Asia DNA And Gene Chip Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe DNA And Gene Chip Market

  • 20.1. Western Europe DNA And Gene Chip Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK DNA And Gene Chip Market

  • 21.1. UK DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany DNA And Gene Chip Market

  • 22.1. Germany DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France DNA And Gene Chip Market

  • 23.1. France DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy DNA And Gene Chip Market

  • 24.1. Italy DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain DNA And Gene Chip Market

  • 25.1. Spain DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe DNA And Gene Chip Market

  • 26.1. Eastern Europe DNA And Gene Chip Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia DNA And Gene Chip Market

  • 27.1. Russia DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America DNA And Gene Chip Market

  • 28.1. North America DNA And Gene Chip Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA DNA And Gene Chip Market

  • 29.1. USA DNA And Gene Chip Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada DNA And Gene Chip Market

  • 30.1. Canada DNA And Gene Chip Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America DNA And Gene Chip Market

  • 31.1. South America DNA And Gene Chip Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil DNA And Gene Chip Market

  • 32.1. Brazil DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East DNA And Gene Chip Market

  • 33.1. Middle East DNA And Gene Chip Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa DNA And Gene Chip Market

  • 34.1. Africa DNA And Gene Chip Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa DNA And Gene Chip Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. DNA And Gene Chip Market Regulatory and Investment Landscape

36. DNA And Gene Chip Market Competitive Landscape And Company Profiles

  • 36.1. DNA And Gene Chip Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. DNA And Gene Chip Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. DNA And Gene Chip Market Company Profiles
    • 36.3.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. CapitalBio Corporation Overview, Products and Services, Strategy and Financial Analysis

37. DNA And Gene Chip Market Other Major And Innovative Companies

  • Microarrays Inc., Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Fluidigm Corporation, LC Sciences, Macrogen Inc., Greiner Bio-One International GmbH, F. Hoffmann-La Roche Ltd, GE Healthcare, Hitachi High-Technologies Corporation

38. Global DNA And Gene Chip Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The DNA And Gene Chip Market

40. DNA And Gene Chip Market High Potential Countries, Segments and Strategies

  • 40.1 DNA And Gene Chip Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 DNA And Gene Chip Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 DNA And Gene Chip Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer